Plunkett Research Online: Juno Therapeutics Inc

JUNO THERAPEUTICS INC (JUNO:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Juno Therapeutics is a biotechnology company with a focus on developing cellular immunotherapies for the treatment of cancer. The company has one business segment, Biotechnology, which is principally engaged in creating cell-based cancer immunotherapies based on chimeric antigen receptor and T cell .....



Juno Therapeutics Inc
Ticker: JUNO
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 206 582-1600
Fax:
Address: 307 Westlake Avenue North
Suite 300
Seattle, WA 98109 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Vaccines, Skin Replacement Products and Biologicals Manufacturing
ContactsDescription
Hans BishopCEO/Co-Founder/Director/President
Steven HarrCFO/Chief Accounting Officer/Other Corporate Officer
See More
Juno Therapeutics is a biotechnology company with a focus on developing cellular immunotherapies for the treatment of cancer. The company has one business segment, Biotechnology, which is principally engaged in creating cell-based cancer immunotherapies based on chimeric antigen receptor and T cell .....See More See More

Auditor: Ernst & Young LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201620152014
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: